Erlotinib
Overview
Erlotinib is a tyrosine kinase inhibitor used in the treatment of non-small cell lung cancer and pancreatic cancer. It works by inhibiting the epidermal growth factor receptor (EGFR), which is involved in the growth and spread of cancer cells.
API suppliers (5)
Suppliers of Erlotinib evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 4 of 5 suppliers.
2 of 5 hold a GMP certificate on record in the EU or UK registers
- MSN Laboratories Private LimitedIndia2 active DMF GMP on record
- CDYMAX (INDIA) PHARMA PRIVATE LIMITEDIndia2 active DMF GMP on record
- SHILPA PHARMA LIFESCIENCES LTDIndia1 active DMF
- CADILA HEALTHCARE LTD ZYFINE
- Cadila Healthcare LimitedIndia
Therapeutic areas
Do you supply Erlotinib? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.